mywy 3 mg/0,02 mg filmsko obložene tablete
sanofi-aventis d.o.o. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,02 mg / 1 tableta; etinilestradiol 0,02 mg / 1 tableta - drospirenon in etinilestradiol
mywy 3 mg/0,02 mg filmsko obložene tablete
sanofi-aventis d.o.o. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,02 mg / 1 tableta; etinilestradiol 0,02 mg / 1 tableta - drospirenon in etinilestradiol
mywy 3 mg/0,02 mg filmsko obložene tablete
sanofi-aventis d.o.o. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,02 mg / 1 tableta; etinilestradiol 0,02 mg / 1 tableta - drospirenon in etinilestradiol
mywy 3 mg/0,02 mg filmsko obložene tablete
sanofi-aventis d.o.o. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,02 mg / 1 tableta; etinilestradiol 0,02 mg / 1 tableta - drospirenon in etinilestradiol
sidretella 0,03 mg/3 mg filmsko obložene tablete
sanofi-aventis d.o.o. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,03 mg / 1 tableta; etinilestradiol 0,03 mg / 1 tableta - drospirenon in etinilestradiol
flexyess 0,02 mg/3 mg filmsko obložene tablete
bayer d.o.o. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,02 mg / 1 tableta; etinilestradiol 0,02 mg / 1 tableta - drospirenon in etinilestradiol
werrca 3 mg/0,03 mg filmsko obložene tablete
gedeon richter plc. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,03 mg / 1 tableta; etinilestradiol 0,03 mg / 1 tableta - drospirenon in etinilestradiol
orserdu
stemline therapeutics b.v. - elacestrant - neoplazme dojke - endokrini terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
zepatier
merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitis c, kronični - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 in 5. za virus hepatitisa c (hcv) genotip-specifična aktivnost glej točki 4. 4 in 5.
ciqorin 10 mg mehke kapsule
teva pharma b.v. - ciklosporin - kapsula, mehka - ciklosporin 10 mg / 1 kapsula - ciklosporin